TNFSF10 and Alzheimer disease: Apparently, after a first attempt of the immune response to restain AD-related brain inflammation by means of TRAIL-driven increase of Treg cells, the latter may assume an overwhelming attitude, thus, limiting the beneficial effects of the immune response against accumulating Aβ [74], allowing the inflammatory response to overshoot, and resulting in noxious effects.